About Neuromuscular Diseases
A look at causes, symptoms, and care options for neuromuscular diseases, and how we're leading the way to better treatments and cures.
Big Picture Perspective
At MDA, we take a big picture perspective across the full spectrum of neuromuscular diseases to uncover scientific and medical breakthroughs that accelerate treatments and cures. The power in our research approach is that we can often apply learnings from one disease to progress in others to bring urgently-needed answers to our families.
Read MDA News to stay up-to-date on issues that matter to the MDA community.
Follow the Biomarkers
Biomarkers can provide crucial information for researchers conducting clinical trials.
Five Questions with DMD Researcher James Ervasti
James Ervasti, professor in the department of biochemistry, molecular biology & biophysics at the University of Minnesota in Minneapolis, is working to develop methods of identifying non-invasive biomarkers.
Keveyis Approved to Treat Periodic Paralysis
The FDA has approved Taro Pharmaceuticals’ Keveyis 50 mg tablets for primary hyperkalemic and hypokalemic periodic paralysis.
MDA helps you keep up on research news, health care information and helpful daily living strategies through magazines, print and online publications, educational speakers, seminars, videos and newsletters.
MDA Resource Center: We’re Here For You
Our trained specialists are here to provide one-on-one support for every part of your journey. Send a message below or call us at 1-833-ASK-MDA1 (1-833-275-6321). If you live outside the U.S., we may be able to connect you to muscular dystrophy groups in your area, but MDA programs are only available in the U.S.